G01N2800/2885 - CPC Classification Index

ClassID:

170851 ⎘

G01N2800/2885 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Neurological disorders; Muscular dystrophy Duchenne dystrophy

Recent Application in this class:

20240425572

2024-12-26

ANTIBODIES AND METHODS OF USING THEREOF

20240003898

2024-01-04

METHODS FOR MEASURING DYSTROPHIN IN TISSUE SAMPLES

20180284136

2018-10-04

COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE

20170258873

2017-09-14

METHODS FOR DIAGNOSING, PROGNOSING AND TREATING MUSCULAR DYSTROPHY

20160324927

2016-11-10

COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE

20150196618

2015-07-16

Methods for diagnosing, prognosing and treating muscular dystrophy

20140038906

2014-02-06

Therapeutic and diagnostic methods involving biglycan and utrophin

20130065242

2013-03-14

Methods for treating muscular dystrophy

20120258093

2012-10-11

VLA-4 AS A BIOMARKER FOR PROGNOSIS AND TARGET FOR THERAPY IN DUCHENNE MUSCULAR DYSTROPHY

#10

20120245095

2012-09-27

Biglycan and related therapeutics and methods of use

#11

20120238478

2012-09-20

PROTEIN MARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF OVARIAN AND BREAST CANCER

#12

20110224128

2011-09-15

METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY

#13

20100130405

2010-05-27

Biglycan and related therapeutics and methods of use

#14

20080213907

2008-09-04

Protein markers for the diagnosis and prognosis of ovarian and breast cancer